Company: CDT
Filing Date: 2025-04-02
Form Type: 8-K/A
Source: 0001641172-25-002400
Chunk: 2

Company: CDT Equity Inc.
Filing Date: 2025-04-02
Form: 8-K/A
Chunk 2
---
 the filing of this Amendment.

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| April   
 2, 2025 | CONDUIT              
 PHARMACEUTICALS INC. 
 By:                  | /s/               
 David Tapolczay   |
|:--------|:---------------------|:------------------|
|         | Name:                | David             
 Tapolczay         |
|         | Title:               | Chief             
 Executive Officer |